HMC Designates Dedicated Treatment Facility For Children With COVID-19 Requiring Hospital Admission
Doha, 10 January 2022: Hamad Medical Corporation (HMC) has designated the Al Wakra Pediatric COVID-19 Center, located on the Al Wakra Hospital campus, as a treatment facility for children with COVID-19 who require hospital admission.
The decision to designate this center as a COVID-19 treatment facility is a proactive measure that has been taken in light of the recent increase in the number of COVID-19 cases in Qatar and around the world to ensure that COVID-19 pediatric patients are given the very best medical care possible. This state-of-the-art facility will enable HMC to provide high quality care for young patients with COVID-19 in one location.
The state-of-the-art health center provides a modern, safe healing environment to ensure pediatric patients who need hospitalization are provided with high quality care and to enable medical teams to provide the best care possible to COVID-19 pediatric patients. The Center provides 39 inpatient beds, including 4 intensive care beds and 22 observation beds for short stay patients. The center has the ability to increase to up to 140 inpatient beds if needed.
The Center will be for only confirmed COVID-19 pediatric patients and will offer two types of services: the first is to evaluate patients and then send them for home isolation, and the second service is for children who require medical observation and need to be admitted for a short stay or for long-term medical observation. Children with suspected COVID-19, displaying signs and symptoms, should visit one of HMC’s four Pediatric Emergency Centers - Al Sadd, Al Dayeen, Airport, Al Rayan - or a primary health center for a COVID-19 test.